WASHINGTON – The U.S. Government Accountability Office (GAO) today released the findings of a study into the Drug Enforcement Agency’s (DEA) implementation of regulations that create potential barriers to the participation of local pharmacies in federal drug take-back programs. The report was requested by Sens.

Washington, D.C. – Congressman Dave Loebsack released the following statement today after he helped lead a bipartisan push to ensure the Congressionally Directed Medical Research Programs (CDMRP) remained within the Department of Defense (DOD). As part of negotiations over the National Defense Authorization Act (NDAA), provisions were struck from the bill that were originally included in the legislation and would have halted the research.

Signing coincides with American Diabetes Month

WASHINGTON – Senate Judiciary Committee Chairman Chuck Grassley is pressing the Centers for Medicare and Medicaid Services (CMS) for answers about hospital accrediting organizations’ access to patient mistreatment complaint databases.